Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma

被引：0
|
作者：
Lee, Jae Woo
Son, Jun Hyuk
Lee, Ban Seok
Lee, Sang Hyub
Jang, Dong Kee
Chung, Kwang Hyun
Ryu, Ji Kon
Kim, Yong-Tae
机构：
[1] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul 151, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Liver Res Inst, Seoul 151, South Korea
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-8-51
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [1] Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
    Lee, S. H.
    Lee, B. S.
    Ryu, J.
    Kim, Y. -T.
    ANNALS OF ONCOLOGY, 2015, 26
  • [2] Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
    Lee, Ban Seok
    Lee, Sang Hyub
    Son, Jun Hyuk
    Jang, Dong Kee
    Chung, Kwang Hyun
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 493 - 500
  • [3] Prognostic value of CA 19-9 in patients with pancreatic cancer treated with Gemcitabine
    Halm, U
    Schuhmann, T
    Keim, V
    Moessner, J
    GASTROENTEROLOGY, 1999, 116 (04) : A1129 - A1129
  • [4] Prognostic value of serum carbohydrate 19-9 in patients receiving gemcitabine-based neoadjuvant therapy for pancreatic cancer
    Mody, Kabir
    Shatzel, Joseph J.
    James, Spencer L.
    Wang, Rebecca
    Colacchlo, Thomas Anthony
    Barth, Richard J.
    Zaki, Bassem I.
    Tsapakos, Michael J.
    Suriawinata, Arief A.
    Sutton, John E.
    Gordon, Stuart R.
    Gardner, Timothy B.
    Smith, Kerrington D.
    Ripple, Gregory H.
    Hourdequin, Kathryn Cunningham
    Tsongalis, Gregory J.
    McGrath, Elizabeth Boutin
    Pipas, J. Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
    Sato, Yuki
    Fujimoto, Daichi
    Uehara, Keiichiro
    Shimizu, Ryoko
    Ito, Jiro
    Kogo, Mariko
    Teraoka, Shunsuke
    Kato, Ryoji
    Nagata, Kazuma
    Nakagawa, Atsushi
    Otsuka, Kojiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Imai, Yukihiro
    Tomii, Keisuke
    BMC CANCER, 2016, 16
  • [6] The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
    Yuki Sato
    Daichi Fujimoto
    Keiichiro Uehara
    Ryoko Shimizu
    Jiro Ito
    Mariko Kogo
    Shunsuke Teraoka
    Ryoji Kato
    Kazuma Nagata
    Atsushi Nakagawa
    Kojiro Otsuka
    Hiroshi Hamakawa
    Yutaka Takahashi
    Yukihiro Imai
    Keisuke Tomii
    BMC Cancer, 16
  • [7] Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    Halm U.
    Schumann T.
    Schiefke I.
    Witzigmann H.
    Mössner J.
    Keim V.
    British Journal of Cancer, 2000, 82 (5) : 1013 - 1016
  • [8] Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    Halm, U
    Schumann, T
    Schiefke, I
    Witzigmann, H
    Mössner, J
    Keim, V
    BRITISH JOURNAL OF CANCER, 2000, 82 (05) : 1013 - 1016
  • [9] Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
    Ziske, C
    Schlie, C
    Gorschlüter, M
    Glasmacher, A
    Mey, U
    Strehl, J
    Sauerbruch, T
    Schmidt-Wolf, IGH
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1413 - 1417
  • [10] Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
    C Ziske
    C Schlie
    M Gorschlüter
    A Glasmacher
    U Mey
    J Strehl
    T Sauerbruch
    I G H Schmidt-Wolf
    British Journal of Cancer, 2003, 89 : 1413 - 1417
12345